Show an ad over header. AMP

I am the FIRST

AstraZeneca commits to releasing more complete vaccine data after concerns from NIH

AstraZeneca acknowledged on Tuesday morning that a press release about its U.S. coronavirus vaccine trial was based on data through Feb. 17, and promised to release more complete results that are "consistent with" the interim data within the next 48 hours.

Why it matters: The National Institute of Allergy and Infectious Diseases (NIAID) released an unusual statement early Tuesday expressing concerns that AstraZeneca's release may have used "outdated information" that "may have provided an incomplete view of the efficacy data."


  • NIAID urged the company to work with the independent Data and Safety Monitoring Board (DSMB), which was cited in the release, to "review the efficacy data and ensure the most accurate, up-to-date efficacy data be made public as quickly as possible."
  • AstraZeneca committed in its statement to "immediately engage" with the DSMB to share its primary analysis, which it said is "consistent with the interim analysis."

Driving the news: Anthony Fauci, who serves as director of NIAID, called AstraZeneca's possible use of outdated information an "unforced error," stressing on Tuesday that "this is very likely a very good vaccine."

  • The British-Swedish pharmaceutical company said an interim analysis of its Phase III U.S. trial had found the vaccine to be 79% effective at preventing symptomatic COVID-19 and 100% effective against severe disease and hospitalization.
  • AstraZeneca also said the data showed no serious side effects among the more than 20,000 participants who received at least one dose — news that was seen as likely to bolster global confidence in a vaccine that was briefly suspended in European countries over concerns about possible blood clots.

What they're saying: "If you look at it, the data are quite good, but when they put it into the press release it wasn't completely accurate," Fauci said on ABC's "Good Morning America."

  • "So we have to keep essentially trying as hard as we can to get people to understand that there are safeguards in place. And I think the Data and Safety Monitoring Board picking up this discrepancy was an example of the safeguard," he continued.
  • "And at the end of the day, Robin, all of this is going to be decided by the FDA. They will independently go over every bit of data themselves and not rely on any interpretation from anyone including the company."

Go deeper: Science is suffering from low research standards

Why the startup world needs to ditch "unicorns" for "dragons"

When Aileen Lee originally coined the term "unicorn" in late 2013, she was describing the 39 "U.S.-based software companies started since 2003 and valued at over $1 billion by public or private market investors."

Flashback: It got redefined in early 2015 by yours truly and Erin Griffith, in a cover story for Fortune, as any privately-held startup valued at $1 billion or more. At the time, we counted 80 of them.

Keep reading... Show less

Scoop: Facebook's new moves to lower News Feed's political volume

Facebook plans to announce that it will de-emphasize political posts and current events content in the News Feed based on negative user feedback, Axios has learned. It also plans to expand tests to limit the amount of political content that people see in their News Feeds to more countries outside of the U.S.

Why it matters: The changes could reduce traffic to some news publishers, particularly companies that post a lot of political content.

Keep reading... Show less

Scoop: Amazon quietly getting into live audio business

Amazon is investing heavily in a new live audio feature that's similar to other live audio offerings like Clubhouse, Twitter Spaces and Spotify's new live audio platform, sources tell Axios.

Why it matters: As with Amazon's efforts in podcasting and music subscriptions, the company sees live audio as a way to bolster the types of content it can offer through its voice assistant, Alexa, and its smart speaker products.

Keep reading... Show less

Hurricane Ida exposes America's precarious energy infrastructure

The powerful hurricane that plunged New Orleans into darkness for what could be weeks is the latest sign that U.S. power systems are not ready for a warmer, more volatile world.

The big picture: “Our current infrastructure is not adequate when it comes to these kinds of weather extremes,” Joshua Rhodes, a University of Texas energy expert, tells Axios.

Keep reading... Show less

"We must go further": 70% of adults in European Union are fully vaccinated

About 70% of adults in the European Union are fully vaccinated against COVID-19, Ursula von der Leyen, the president of the European Commission, said Tuesday.

Why it matters: The milestone makes the E.U. one of the world's leaders in inoculations, after an initially lagging vaccine campaign, the New York Times notes.

Keep reading... Show less

What Elizabeth Holmes jurors will be asked ahead of fraud trial

Jury selection begins today in USA v. Elizabeth Holmes, with the actual jury trial to get underway on Sept. 8.

Why it matters: Theranos was the biggest fraud in Silicon Valley history, putting both hundreds of millions of dollars and thousands of patients' health at risk.

Keep reading... Show less

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories